Adlai Nortye Ltd.
Adlai Nortye Ltd. (ANL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANL · as of Jun 8, 2026
Key Statistics
Explore Adlai Nortye Ltd. Data
anl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
The ANL analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $26.00, representing +161.31% upside from the current price of $9.95.
Competitors & Peers
anl competitorsANL
ADAP
ADTX
AIMD
APLM
BLRXStock Performance
Full HistoryAbout Adlai Nortye Ltd.
Adlai Nortye Ltd. a clinical-stage biotechnology company, engages in the research and development of pharmaceutical products. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, wh…
what is adlai nortye ltd. · anl stock overview · adlai nortye ltd. company profile · who is adlai nortye ltd. ceo · anl NASDAQ · adlai nortye ltd. headquarters · adlai nortye ltd. business segments
About Stock Overview & Key Data
Adlai Nortye Ltd. (ANL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 29, 2023. As of the latest trading session, ANL stock price is $9.95, with a market capitalization of $525.2M. The stock has returned +514.60% over the past 12 months and +596.83% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Adlai Nortye Ltd. stock is Buy, with an average 12-month price target of $26.00. In fiscal year 2025, Adlai Nortye Ltd. reported revenue of $5.0M and net income of -$35.5M. For detailed data — including Adlai Nortye Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Adlai Nortye Ltd. (ANL) stock price is $9.95. The stock is traded on NASDAQ under the ticker symbol ANL. The 52-week range is $0.88 – $17.25.